Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of 7.78% is 21% above its 5-year average of 6.41%, near the high end of its 5-year range (4.66%–7.93%).
As of the fiscal period ended Wednesday, December 31, 2025. 13.16% above its 12-month average of 6.88%.
Annual fiscal-year return on assets; no daily interpolation.
RETURN ON ASSETS (ROA)
7.78%
RETURN ON ASSETS (ROA) AVG TTM
6.88%
RETURN ON ASSETS (ROA) AVG 3Y
7.02%
RETURN ON ASSETS (ROA) AVG 5Y
6.41%
RETURN ON ASSETS (ROA) AVG 10Y
7.27%
RETURN ON ASSETS (ROA) AVG 15Y
7.59%
RETURN ON ASSETS (ROA) AVG 20Y
9.02%
CURRENT VS TTM AVG
+13.16%
CURRENT VS 3Y AVG
+10.87%
CURRENT VS 5Y AVG
+21.28%
CURRENT VS 10Y AVG
+7.03%
CURRENT VS 15Y AVG
+2.51%
CURRENT VS 20Y AVG
-13.77%
SECTOR MEDIAN · HEALTHCARE
4.91%
median of 79 covered companies
CURRENT VS SECTOR MEDIAN
+58.45%
vs the sector median at left
Stryker Corporation
Market Cap
$124.86B
Return on Assets (ROA)
7.78%
TTM Avg
6.88%
3Y Avg
7.02%
5Y Avg
6.41%
Market Cap
$124.82B
Return on Assets (ROA)
15.04%
TTM Avg
13.09%
3Y Avg
12.00%
5Y Avg
11.68%
Market Cap
$121.09B
Return on Assets (ROA)
16.38%
TTM Avg
6.37%
3Y Avg
11.74%
5Y Avg
14.58%
Market Cap
$131.47B
Return on Assets (ROA)
9.11%
TTM Avg
7.88%
3Y Avg
6.26%
5Y Avg
4.99%
Market Cap
$133.25B
Return on Assets (ROA)
1.16%
TTM Avg
1.25%
3Y Avg
1.93%
5Y Avg
2.38%
Market Cap
$133.37B
Return on Assets (ROA)
10.59%
TTM Avg
-0.92%
3Y Avg
3.28%
5Y Avg
1.99%
Market Cap
$137.13B
Return on Assets (ROA)
4.33%
TTM Avg
4.68%
3Y Avg
5.89%
5Y Avg
6.01%
Market Cap
$109.30B
Return on Assets (ROA)
5.16%
TTM Avg
5.13%
3Y Avg
4.62%
5Y Avg
4.65%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Stryker Corporation (SYK) | $124.86B | 7.78% | 6.88% | 7.02% | 6.41% |
| Intuitive Surgical, Inc. (ISRG)vs › | $124.82B | 15.04% | 13.09% | 12.00% | 11.68% |
| Vertex Pharmaceuticals Incorporated (VRTX)vs › | $121.09B | 16.38% | 6.37% | 11.74% | 14.58% |
| AstraZeneca PLC (AZN)vs › | $131.47B | 9.11% | 7.88% | 6.26% | 4.99% |
| CVS Health Corp. (CVS)vs › | $133.25B | 1.16% | 1.25% | 1.93% | 2.38% |
| Bristol-Myers Squibb Company (BMY)vs › | $133.37B | 10.59% | -0.92% | 3.28% | 1.99% |
| Danaher Corporation (DHR)vs › | $137.13B | 4.33% | 4.68% | 5.89% | 6.01% |
| Medtronic plc (MDT)vs › | $109.30B | 5.16% | 5.13% | 4.62% | 4.65% |
| Pfizer Inc. (PFE)vs › | $142.54B | 3.61% | 3.75% | 6.08% | 7.08% |
| GSK plc (GSK)vs › | $103.56B | 7.15% | 6.85% | 11.28% | 9.07% |
ROA
7.8%
ROE
7.8%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | 6.78% |
| 2024-12-31 | 6.97% |
| 2023-12-31 | 7.93% |
| 2022-12-31 | 6.39% |
| 2021-12-31 | 5.76% |
| 2020-12-31 | 4.66% |
| 2019-12-31 | 6.90% |
| 2018-12-31 | 13.05% |
| 2017-12-31 | 4.60% |
| 2016-12-31 | 8.06% |
| 2015-12-31 | 8.86% |
| 2014-12-31 | 2.91% |
| 2013-12-31 | 6.39% |
| 2012-12-31 | 9.64% |
| 2011-12-31 | 10.84% |
| 2010-12-31 | 11.69% |
| 2009-12-31 | 12.21% |
| 2008-12-31 | 15.10% |
| 2007-12-31 | 13.83% |
| 2006-12-31 | 13.24% |
| 2005-12-31 | 13.66% |
| 2004-12-31 | 11.40% |
| 2003-12-31 | 14.36% |
| 2002-12-31 | 12.27% |
| 2001-12-31 | 11.02% |
| 2000-12-31 | 9.09% |
| 1999-12-31 | 0.75% |
| 1998-12-31 | 1.37% |
| 1997-12-31 | 12.72% |
| 1996-12-31 | 10.52% |
